(Q34853625)

English

Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

anti-retroviral agent

0 references

Gilda Tachedjian

object named as

Gilda Tachedjian

7

0 references

object named as

Andrew Owen

11

0 references

Andrew N Phillips

12

object named as

Andrew Phillips

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Lieven J Stuyver

6

object named as

Lieven J Stuyver

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Anna Maria Geretti

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Zoe Fox

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Jeffrey A Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Clare Booth

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Jonathan Lipscomb

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

John Baxter

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Giota Touloumi

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Clara Lehmann

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

18 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

e69266

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

copyright license

Creative Commons Attribution 4.0 International

18 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Presence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Minority variants of drug-resistant HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Host determinants of antiretroviral drug activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Pharmacology of antiretroviral drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715458

8 July 2018

Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069266

21 January 2018

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069266

21 January 2018

Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069266

21 January 2018

Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069266

21 January 2018

Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069266

21 January 2018

Ultra-Deep Sequencing of HIV-1 Reverse Transcriptase Before Start of an NNRTI-based Regimen in Treatment-naive Patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0069266

21 January 2018

Identifiers

10.1371/JOURNAL.PONE.0069266

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

2013PLoSO...869266G

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34853625&oldid=1864403925"